|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 | |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
BETA-NERVE GROWTH FACTOR, HUMAN (CAS 86923-98-0) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Drugs in Development, 2021 ... autophosphorylates tyrosine residues in the beta subunit thus initiates a ... Infarction), Diabetic Retinopathy, Human Epidermal Growth Factor Receptor 2 Negative Breast ... Cancer, Parkinson's Disease, Peripheral Nerve Injury, Peripheral Neuropathy (Sensory ... Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update ... autophosphorylates tyrosine residues in the beta subunit thus initiates a cascade ... Cancer, Diabetic Retinopathy, Human Epidermal Growth Factor Receptor 2 Negative Breast ... Cancer, Parkinson's Disease, Peripheral Nerve Injury, Peripheral Neuropathy (Sensory ... 2024 World Cancer Diagnostics Market: A 75-Country Analysis-Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Emerging Technologies, Latest Instrumentation, Growth Opportunities This new 75-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test. The report is available by section, and can be customized to specific information needs and budget. This report is ... 2021 Global Cancer Diagnostics Market Assessment: USA, Europe, Japan-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report is available by section, and can be customized to specific information needs and ... 2021 Global Cancer Diagnostics Market Perspective: USA, Europe, Japan-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report is available by section, and can be customized to specific information needs and ... 2021-2025 Global Cancer Diagnostics Market Outlook: USA, Europe, Japan-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report is available by section, and can be customized to specific information needs and ... 2022-2026 Global Cancer Diagnostics Market Opportunities for Major Tumor Markers: USA, Europe, Japan-Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report is available by section, and can be customized to specific information needs and ... 2022-2026 Global Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers-US, Europe, Japan-Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report is available by section, and can be customized to specific information needs and ... 2023-2027 Global Tumor Markers Testing Market-High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers-US, Europe, Japan-Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years.The report is available by section, and can be customized to specific information needs and ... 2023-2027 Middle East Tumor Markers Testing Market-High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers-An 11-Country Analysis-Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.The report is available by section, and can be customized to specific information needs and budget. This report is designed to ... Glaucoma Therapeutics Market Report by Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgery Centers, and Others), and Region 2025-2033 ... optic nerve damage, supporting the market growth. Besides ... performance in animal and human models. A spinout, Vzarii ... Class: Prostaglandin Analogs Beta Blockers Alpha Adrenergic ... influenced by a diverse range of factors such as affordability, varied ... Future Horizons and Growth Strategies in the Global Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years - Examines trends in the U. S., ... Future Horizons and Growth Strategies in the Global Cancer Diagnostics Market 2015: Supplier Shares and Country Forecasts Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. “Future Horizons and Growth Strategies in the Global Cancer Diagnostics Market 2015” is a new seven-country strategic analysis of the major business opportunities ... Future Horizons and Growth Strategies in the European Cancer Diagnostics Market 2015: Supplier Shares and Country Forecasts Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. “Future Horizons and Growth Strategies in the European Cancer Diagnostics Market 2015” is a new five-country strategic analysis of the major business opportunities ... 2015-2019 Global Tumor Marker Testing Market: US, Europe, Japan - Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years; Examines trends in the U.S., Europe ... 2015-2019 Future Horizons and Growth Strategies in the Global Tumor Marker Testing Market: Supplier Shares and Country Forecasts Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. HIGHLIGHTS Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years Examines trends in the U.S., Europe ... 2016 World Emerging Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years - Examines trends in the U. S., ... 2016 Future Horizons and Growth Strategies in the World Cancer Diagnostics Market: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. 2016 Future Horizons and Growth Strategies in the World Cancer Diagnostics Market is a new seven-country strategic analysis of the major business opportunities ... 2016 Future Horizons and Growth Strategies in the Global Tumor Marker Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities Complete report $34,750. DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights Identifies and evaluates major business opportunities emerging in the tumor marker market during the next five years; Examines trends in the U.S., Europe ... |